Titan Pharmaceuticals, Inc. (TTNP)

NASDAQ: TTNP · IEX Real-Time Price · USD

7.01

-0.01 (-0.14%)

At close: Apr 22, 2024, 4:00 PM

6.80

-0.21 (-3.00%)

Pre-market: Apr 23, 2024, 8:25 AM EDT

Titan Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Revenue	0.18	0.56	1.53	4.84	2.61	6.62	0.22	15.07	1.67	3.65	Upgrade
Revenue Growth (YoY)	-66.97%	-63.50%	-68.46%	85.72%	-60.64%	2978.14%	-98.57%	801.56%	-54.17%	-65.21%	Upgrade
Cost of Revenue	0	0	0.2	0.47	0	0.54	0	0	0	0	Upgrade
Gross Profit	0.18	0.56	1.33	4.37	2.61	6.08	0.22	15.07	1.67	3.65	Upgrade
Selling, General & Admin	5.55	6.03	4.99	5.8	5.4	6.87	5.07	4.6	3.76	3.05	Upgrade
Research & Development	1.91	4.76	5.69	5.92	5.08	7.48	9.65	6.13	4.68	4.08	Upgrade
Operating Expenses	7.46	10.79	10.68	11.72	10.48	14.34	14.72	10.72	8.43	7.12	Upgrade
Operating Income	-7.28	-10.24	-9.35	-7.35	-7.88	-8.26	-14.5	4.34	-6.76	-3.48	Upgrade
Interest Expense / Income	0	0	0	0.77	0.97	0.89	0.37	-0.04	0	0	Upgrade
Other Expense / Income	-1.71	-0.03	-0.58	10.12	7.62	-0.13	-0.56	-0.76	4.52	-1.07	Upgrade
Pretax Income	-5.57	-10.21	-8.78	-18.24	-16.46	-9.02	-14.31	5.14	-11.28	-2.4	Upgrade
Net Income	-5.57	-10.21	-8.78	-18.24	-16.46	-9.02	-14.31	5.14	-11.28	-2.4	Upgrade
Preferred Dividends	0	0	0	0	0	0.29	0	0	0	0	Upgrade
Net Income Common	-5.57	-10.21	-8.78	-18.24	-16.46	-9.31	-14.31	5.14	-11.28	-2.4	Upgrade
Shares Outstanding (Basic)	1	1	0	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	0	0	0	0	0	0	0	0	Upgrade
Shares Change	11.90%	38.13%	157.88%	392.56%	304.01%	60.76%	-1.09%	7.04%	17.54%	13.51%	Upgrade
EPS (Basic)	-7.41	-15.19	-18.00	-96.60	-429.80	-984.00	-2430.00	894.00	-2015.96	-503.99	Upgrade
EPS (Diluted)	-7.41	-15.19	-18.00	-96.60	-429.80	-996.00	-2532.00	720.00	-2015.96	-719.99	Upgrade
Free Cash Flow	-7.09	-8.18	-7.92	-17.74	-15.7	-8.85	-12.85	6.12	-7.6	-5.88	Upgrade
Free Cash Flow Per Share	-9.43	-12.18	-16.28	-94.05	-409.95	-933.23	-2182.00	1062.48	-1364.27	-1241.66	Upgrade
Gross Margin	100.00%	100.00%	86.96%	90.24%	100.00%	91.87%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-3954.89%	-1837.52%	-612.98%	-151.94%	-302.34%	-124.87%	-6745.12%	28.83%	-404.49%	-95.31%	Upgrade
Profit Margin	-3026.63%	-1832.32%	-575.10%	-377.06%	-631.79%	-140.65%	-6654.42%	34.09%	-674.99%	-65.91%	Upgrade
Free Cash Flow Margin	-3855.43%	-1469.12%	-519.13%	-366.74%	-602.73%	-133.68%	-5977.67%	40.64%	-454.76%	-161.35%	Upgrade
EBITDA	-5.46	-10.01	-8.56	-17.18	-15.25	-7.76	-13.52	5.48	-10.92	-2.05	Upgrade
EBITDA Margin	-2965.76%	-1797.13%	-560.62%	-355.13%	-585.30%	-117.20%	-6288.84%	36.34%	-653.56%	-56.23%	Upgrade
Depreciation & Amortization	0.11	0.2	0.22	0.29	0.24	0.38	0.42	0.38	0.36	0.35	Upgrade
EBIT	-5.57	-10.21	-8.78	-17.47	-15.49	-8.14	-13.94	5.1	-11.28	-2.4	Upgrade
EBIT Margin	-3026.63%	-1832.32%	-575.10%	-361.16%	-594.66%	-122.94%	-6482.79%	33.84%	-674.99%	-65.91%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).